Reference Pricing Policies
Reference Pricing Policies is a formulary design strategy that establishes a benchmark price for a group of therapeutically equivalent medications, from which patient cost-sharing and reimbursement levels are determined, distinguishing it from other pricing mechanisms by its reliance on internal or external price comparability to control pharmaceutical expenditures.
106
Publications
4.8K
Citations
263
Authors
175
Institutions
Publications per year
2017–2026
26
Parents
106
Policies for biosimilar uptake in Europe: An overview
Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text
1–5 of 106
263
9
h-index
8
h-index
6
h-index
6
h-index
6
h-index
1–5 of 263
175
Harvard University
Cambridge, United States
9 h-index
18 publications
728 citations
Norwegian School of Economics
Bergen, Norway
8 h-index
11 publications
470 citations
University of Minho
Braga, Portugal
7 h-index
7 publications
370 citations
University of California, Berkeley
Berkeley, United States
7 h-index
17 publications
679 citations
Berkeley Public Health Division
Berkeley, United States
6 h-index
8 publications
331 citations
Ifo Institute for Economic Research
Munich, Germany
5 h-index
9 publications
203 citations
University of Bergen
Bergen, Norway
5 h-index
6 publications
240 citations

Brigham and Women's Hospital
Boston, United States
4 h-index
7 publications
164 citations
1–8 of 175
Repository · 13 publications · 276 citations
12
h-index
Repository · 11 publications · 521 citations
11
h-index
9 publications · 474 citations
9
h-index
7 publications · 474 citations
7
h-index
6 publications · 233 citations
6
h-index
1–5